Thyroid Eye Disease: Multidisciplinary Management of Treatment-Associated Hearing Loss (Online CME Monograph)
This educational activity is intended to help clinicians evaluate real-world data pertaining to hearing dysfunction associated with thyroid eye disease treatment with the insulin-like growth factor 1 receptor antagonist teprotumumab.
Category
  • Ophthalmology
  • Ophthalmology/Neuro-Ophthalmic
Format
  • Monograph
Credits
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Participation
Thyroid Eye Disease: Updates on Comprehensive Management (CME Webcast)
This CME/CE webcast is designed for clinicians seeking to enhance their understanding and management of thyroid eye disease.
Category
  • Ophthalmology
  • Ophthalmology/Neuro-Ophthalmic
Format
  • Webcast
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation